Primary gastric lymphoma of T-cell origin: clinicopathologic features and treatment outcome.
We conducted a retrospective analysis to investigate the natural history and the clinical outcome after treatment of primary gastric lymphoma of T-cell origin. Seventeen cases of T-cell origin among 444 primary gastric lymphoma patients were analyzed. The median age of the 14 male and 3 female patients was 49 years (range 22-76 years). The median progression-free survival (PFS) and overall survival (OS) were only 10 months (95% CI; 0-20 months), and 12 months (95% CI; 4-21 months), respectively. This study showed that the incidence of this subtype of T-cell gastric lymphoma was very rare, and had poor prognosis.
Park
Yeon Hee
YH
Department of Hematology-Oncology, Korea Institute of Radiological & Medical Sciences, Nowon-ku, Seoul, Republic of Korea. yhpark1229@yahoo.com
Kim
Won Seog
WS
Bang
Soo Mee
SM
Lee
Soon Il
SI
Kang
Hye Jin
HJ
Na
Im Il
II
Yang
Sung Hyun
SH
Lee
Seung-Sook
SS
Uhm
Ji Eun
JE
Kwon
Jung Mi
JM
Kim
Kihyun
K
Jung
Chul Won
CW
Park
Keunchil
K
Ko
Young H
YH
Ryoo
Baek-Yeol
BY
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D016019:Survival Analysis; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone